Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

9.16 (USD) • At close September 18, 2024
Bedrijfsnaam Maravai LifeSciences Holdings, Inc.
Symbool MRVI
Munteenheid USD
Prijs 9.16
Beurswaarde 2,310,494,016
Dividendpercentage 0%
52-weken bereik 4.52 - 11.555
Industrie Biotechnology
Sector Healthcare
CEO Mr. Carl W. Hull
Website https://www.maravai.com

An error occurred while fetching data.

Over Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic

Vergelijkbare Aandelen

Bruker Corporation logo

Bruker Corporation

BRKR

66.8 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

69.21 USD

Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

JAZZ

109.565 USD

Repligen Corporation logo

Repligen Corporation

RGEN

142.03 USD

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

26.71 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

119.85 USD

NovoCure Limited logo

NovoCure Limited

NVCR

17.61 USD

Masimo Corporation logo

Masimo Corporation

MASI

114.31 USD

United Therapeutics Corporation logo

United Therapeutics Corporation

UTHR

342.59 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)